1. Department of Hematology, Oncology and Tumor Immunology, and Berlin Institute of Health, Charité – Universitätsmedizin Berlin, Berlin, Germany;
2. Berlin Institute of Health (BIH), BIH Biomedical Innovation Academy, Berlin, Germany;
3. Molekularpathologie Südbayern, Munich, Germany;
4. Institute of Pathology, University Hospital Erlangen, Erlangen, Germany;
5. Institute of Pathology, Klinikum Kaufbeuren, Kaufbeuren, Germany;
6. Institute of Pathology, Rosenheim, Germany;
7. Department of Pathology, Charité-Universitätsmedizin, Berlin, Germany;
8. Department of Internal Medicine III, University Hospital Munich, Munich, Germany;
9. Translational Oncology, Department of Medicine A, University Hospital Münster, Münster, Germany;
10. Cluster of Excellence EXC 1003, Cells in Motion, Münster, Germany